Últimas Noticias del Cáncer

Gilteritinib Approved for Advanced Acute Myeloid Leukemia (AML) with a FLT3 Mutation (11-29-2018)
The U.S. Food and Drug Administration approved Xospata (gilteritinib) for treatment of adult patients who have recurrent or refractory acute myeloid leukemia (AML) with a FLT3 mutation. About Xospata Xospata... Continue Reading

Tissue “Agnostic” Genomic Based Treatment With Vitrakvi and Keytruda – A Paradigm Shift in Cancer Treatment (11-28-2018)
The US Food and Drug Administration (FDA) on Monday approved a new precision cancer medicine Vitrakvi (larotrectinib) for the treatment of adult and pediatric solid tumors that have a targetable biomarker... Continue Reading

FDA Approves Venclexta Combination for AML in Adults (11-26-2018)
The Food and Drug Administration granted accelerated approval to Venclexta (venetoclax) in combination with azacitidine or decitabine or low-dose cytarabine for the treatment of newly-diagnosed acute myeloid... Continue Reading

More Cancer News

Ubicaciones

MONTEREY
5 Harris Court, Edificio T, Suite 201
Monterey, CA 93940
(Teléfono) 831-375-4105 (fax) 831-372-5722
Haz clic aquí para ver el mapa

 
 
 
 

MORGAN HILL
18525 Sutter Boulevard, Suite 170
Morgan Hill, CA 95037
(Teléfono) 408-779-9843 (fax)408-779-9874
Haz clic aquí para ver el mapa